OraSure Technologies Inc (OSUR)
4.075
-0.20
(-4.57%)
USD |
NASDAQ |
Jul 02, 16:00
4.075
0.00 (0.00%)
After-Hours: 20:00
OraSure Technologies Research and Development Expense (TTM): 30.91M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 30.91M |
| December 31, 2023 | 33.73M |
| September 30, 2023 | 34.79M |
| June 30, 2023 | 36.36M |
| March 31, 2023 | 38.16M |
| December 31, 2022 | 36.24M |
| September 30, 2022 | 37.08M |
| June 30, 2022 | 35.59M |
| March 31, 2022 | 33.81M |
| December 31, 2021 | 34.17M |
| September 30, 2021 | 35.73M |
| June 30, 2021 | 35.14M |
| March 31, 2021 | 34.38M |
| December 31, 2020 | 31.03M |
| September 30, 2020 | 26.68M |
| June 30, 2020 | 23.29M |
| March 31, 2020 | 20.90M |
| December 31, 2019 | 19.63M |
| September 30, 2019 | 17.58M |
| June 30, 2019 | 16.82M |
| March 31, 2019 | 16.55M |
| December 31, 2018 | 16.25M |
| September 30, 2018 | 16.02M |
| June 30, 2018 | 15.39M |
| March 31, 2018 | 14.47M |
| Date | Value |
|---|---|
| December 31, 2017 | 13.36M |
| September 30, 2017 | 10.74M |
| June 30, 2017 | 10.71M |
| March 31, 2017 | 10.36M |
| December 31, 2016 | 9.754M |
| September 30, 2016 | 11.24M |
| June 30, 2016 | 10.57M |
| March 31, 2016 | 10.58M |
| December 31, 2015 | 11.65M |
| September 30, 2015 | 12.78M |
| June 30, 2015 | 13.24M |
| March 31, 2015 | 13.02M |
| December 31, 2014 | 12.06M |
| September 30, 2014 | 10.45M |
| June 30, 2014 | 10.13M |
| March 31, 2014 | 10.06M |
| December 31, 2013 | 10.93M |
| September 30, 2013 | 11.61M |
| June 30, 2013 | 11.94M |
| March 31, 2013 | 12.36M |
| December 31, 2012 | 12.44M |
| September 30, 2012 | 12.85M |
| June 30, 2012 | 15.40M |
| March 31, 2012 | 17.43M |
| December 31, 2011 | 18.41M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
17.58M
Minimum
Sep 2019
38.16M
Maximum
Mar 2023
31.33M
Average
34.17M
Median
Dec 2021
Research and Development Expense (TTM) Benchmarks
| Integra Lifesciences Holdings Corp | 104.43M |
| Insulet Corp | 205.10M |
| Perspective Therapeutics Inc | 24.91M |
| Xtant Medical Holdings Inc | 1.689M |
| Asensus Surgical Inc | 34.98M |